Anand Mehta, D.Phil., is an Associate Professor of Microbiology and Immunology, Drexel University College of Medicine. Dr. Mehta received his graduate degree in Biochemistry from the University of Oxford. Dr. Mehta was one of the first to examine total serum for changes in glycosylation as a function of cancer development. By combining glycomics with proteomics, Dr. Mehta discovered several biomarkers of liver disease and liver cancer, some of which are already available commercially in Asia (GP73, HotGen Biotech, Beijing, China) or under development in the USA. Anand Mehta, D.Phil., is an Associate Professor of Microbiology and Immunology, Drexel University College of Medicine. Dr. Mehta received his graduate degree in Biochemistry from the University of Oxford. Dr. Mehta was one of the first to examine total serum for changes in glycosylation as a function of cancer development. By combining glycomics with proteomics, Dr. Mehta discovered several biomarkers of liver disease and liver cancer, some of which are already available commercially in Asia (GP73, HotGen Biotech, Beijing, China) or under development in the USA.

cancer biomarker, Oncology